当前位置： SCI文献检索 > VACCINE期刊下所有文献 > High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine.

High expression of MAGE-A4 and MHC class I antigens in tumor cells and induction of MAGE-A4 immune responses are prognostic markers of CHP-MAGE-A4 cancer vaccine.

Abstract：

PURPOSE:We conducted a cancer vaccine clinical trial with MAGE-A4 protein. Safety, clinical response, and antigen-specific immune responses were analyzed and the prognostic factors by vaccination were investigated. EXPERIMENTAL DESIGN:Twenty patients with advanced esophageal, stomach or lung cancer were administered MAGE-A4 vaccine containing 300μg protein subcutaneously once every 2 weeks in six doses. Primary endpoints of this study were safety and MAGE-A4 immune responses. RESULTS:The vaccine was well tolerated. Fifteen of 20 patients completed one cycle of vaccination and two patients showed SD. A MAGE-A4-specific humoral immune response was observed in four patients who had high expression of MAGE-A4 and MHC class I on tumor cells. These four patients showed significantly longer overall survival than patients without an antibody response after vaccination (p=0.009). Patients with tumor cells expressing high MAGE-A4 or MHC class I antigen showed significantly longer overall survival than those with low expression. Induction of CD4 and CD8T cell responses was observed in three and six patients, respectively, and patients with induction of MAGE-A4-specific IFNγ-producing CD8T cells, but not CD4T cells, lived longer than those without induction. CONCLUSIONS:The CHP-MAGE-A4 vaccine was safe. Expression of MAGE-A4 and MHC class I in tumor tissue and the induction of a MAGE-A4-specific immune response after vaccination would be feasible prognostic markers for patients vaccinated with MAGE-A4.

journal_name

Vaccine

journal_title

Vaccine

authors

Saito T,Wada H,Yamasaki M,Miyata H,Nishikawa H,Sato E,Kageyama S,Shiku H,Mori M,Doki Y

doi

10.1016/j.vaccine.2014.09.002

subject

Has Abstract

pub_date

2014-10-14 00:00:00

pages

5901-7

issue

45

eissn

0264-410X

issn

1873-2518

pii

S0264-410X(14)01217-1

journal_volume

32

pub_type

杂志文章

相关文献

VACCINE文献大全

Beliefs around childhood vaccines in the United States: A systematic review.
abstract：BACKGROUND:While childhood vaccines are safe and effective, some parents remain hesitant to vaccinate their children, which has led to outbreaks of vaccine preventable diseases. The goal of this systematic review was to identify and summarize the range of beliefs around childhood vaccines elicited using open-ended ques...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2019.08.068

authors： Gidengil C,Chen C,Parker AM,Nowak S,Matthews L

更新日期：2019-10-23 00:00:00
Induction of T-cell response by a DNA vaccine encoding a novel HLA-A*0201 severe acute respiratory syndrome coronavirus epitope.
abstract：:The severe acute respiratory syndrome coronavirus nucleocapsid protein (SARS-CoV N) is one of the major targets for SARS vaccine due to its high potency in triggering immune responses. In this study, we have identified a novel HLA-A*0201 restricted epitope, N220 (LALLLLDRL), of the SARS-CoV N-protein through bioinform...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2007.05.025

authors： Cheung YK,Cheng SC,Sin FW,Chan KT,Xie Y

更新日期：2007-08-10 00:00:00
Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits.
abstract：:Millions of people worldwide are currently infected with human papillomaviruses (HPVs). A therapeutic HPV vaccine would have widespread applicability because HPV-associated lesions are difficult to treat and may progress to carcinoma. We developed three attenuated VSV recombinants expressing the cottontail rabbit papi...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2006.08.012

authors： Brandsma JL,Shlyankevich M,Buonocore L,Roberts A,Becker SM,Rose JK

更新日期：2007-01-08 00:00:00
Seroprevalence of pertussis among healthcare workers: A cross-sectional study from Tunisia.
abstract：:This cross-sectional study aimed to assess pertussis seroprevalence among healthy healthcare workers (HCW) of the Children's Hospital of Tunis, Tunisia. During the study period, 236 blood samples were obtained to determine HCW exposure to pertussis. Concentrations of immunoglobulin G (IgG) to pertussis toxin (PT) were...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2018.11.023

authors： Ben Fraj I,Smaoui H,Zghal M,Sassi O,Guiso N,Kechrid A

更新日期：2019-01-03 00:00:00
The impact of private use of PCV7 in 2009 and 2010 on serotypes and antimicrobial resistance of Streptococcus pneumoniae carried by young children in Portugal: Comparison with data obtained since 1996 generating a 15-year study prior to PCV13 introduction
abstract：:In Portugal, the 7-valent pneumococcal conjugate vaccine (PCV7) was not introduced in the national immunization plan but was commercially available between 2001 and 2010. We studied serotype distribution and antibiotic susceptibility of Streptococcus pneumoniae carried by children in 2009 and 2010. Vaccination with PC...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2016.02.045

authors： Nunes S,Félix S,Valente C,Simões AS,Tavares DA,Almeida ST,Paulo AC,Brito-Avô A,de Lencastre H,Sá-Leão R

更新日期：2016-03-29 00:00:00
Combination vaccines in the South African setting.
abstract：:The number of vaccines available and included as part of the national immunization schedules, has increased significantly over the past few decades. This impacts on patient/parent compliance and creates a challenge for health care providers for implementation of schedules necessitating training and infrastructure impr...

journal_title：Vaccine

pub_type： 杂志文章,评审

doi：10.1016/j.vaccine.2012.05.001

authors： Visser A,Hoosen A

更新日期：2012-09-07 00:00:00
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits.
abstract：:Biodegradable nanoparticles coated with proteins represent a promising method for in vivo delivery of vaccines. Here we used a rabbit model to compare quantitatively and qualitatively the antibody responses induced by poly(D,L-lactide) nanoparticles (PLA) and by emulsion adjuvant MF59 using three HIV-1 antigens: p24ga...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2007.08.060

authors： Guillon C,Mayol K,Terrat C,Compagnon C,Primard C,Charles MH,Delair T,Munier S,Verrier B

更新日期：2007-10-23 00:00:00
Going social: Success in online recruitment of men who have sex with men for prevention HIV vaccine research.
abstract：OBJECTIVE:To compare the use of four different social media sites to recruit men who have sex with men (MSM) and transgender women to a phase 2b HIV prevention vaccine trial, HVTN 505. DESIGN:Retrospective, observational study. METHODS:The University of Pennsylvania HIV Vaccine Trials Unit (Penn HVTU) employed street...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2017.05.002

authors： Buckingham L,Becher J,Voytek CD,Fiore D,Dunbar D,Davis-Vogel A,Metzger DS,Frank I

更新日期：2017-06-14 00:00:00
Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle.
abstract：:Safe RSV vaccine development has challenged the medical community since a formalin-killed RSV vaccine caused disease exacerbation in the 1960s. Disease was replicated using the bovine RSV system in one of two studies. The studies differed in viral protein dose and length of time between vaccination and infection. Dise...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2003.10.024

authors： Kalina WV,Woolums AR,Berghaus RD,Gershwin LJ

更新日期：2004-03-29 00:00:00
The fight against rabies in Africa: From recognition to action.
abstract：:As a follow-up to the first AfroREB meeting, held in Grand Bassam (Côte d'Ivoire) in March 2008, African rabies experts of the AfroREB network met a second time to complete the evaluation of the rabies situation in Africa and define specific action plans. About 40 French speaking rabies specialists from northern, west...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2009.06.030

authors： Dodet B,Africa Rabies Bureau (AfroREB).

更新日期：2009-08-13 00:00:00
Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults
abstract：:The annual contact for influenza vaccination provides an opportunity to ensure that adults have received other recommended vaccines such as Tdap. Healthy 19-64 year-olds were randomized to receive concomitant administration of Tdap and influenza vaccines or influenza vaccine followed (in 4-6 weeks by) Tdap. 720 partic...

journal_title：Vaccine

pub_type： 杂志文章,多中心研究,随机对照试验

doi：10.1016/j.vaccine.2006.12.047

authors： McNeil SA,Noya F,Dionne M,Predy G,Meekison W,Ojah C,Ferro S,Mills EL,Langley JM,Halperin SA

更新日期：2007-04-30 00:00:00
Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
abstract：:Tick-borne encephalitis (TBE) is a potentially serious disease, especially in adults. There is no treatment available for TBE; supportive therapy may help to ease symptoms of the disease. Vaccination is the most effective method of preventing TBE disease and is recommended for those who live, work, or travel in TBE-en...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2008.11.082

authors： Plentz A,Jilg W,Schwarz TF,Kuhr HB,Zent O

更新日期：2009-02-05 00:00:00
Influenza vaccination coverage in adults belonging to defined target groups, Germany, 2003/2004.
abstract：:In 2003, a nationwide cross-sectional study was conducted to assess the current influenza vaccination coverage of the adult population of Germany, especially in persons belonging to defined target groups. Of 666 surveyed persons, 190 (adjusted 24%) had received influenza vaccination and 419 participants belonged to at...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2005.12.020

authors： Wiese-Posselt M,Leitmeyer K,Hamouda O,Bocter N,Zöllner I,Haas W,Ammon A

更新日期：2006-03-24 00:00:00
Use of mobile phones for improving vaccination coverage among children living in rural hard-to-reach areas and urban streets of Bangladesh.
abstract：:In Bangladesh, full vaccination rates among children living in rural hard-to-reach areas and urban streets are low. We conducted a quasi-experimental pre-post study of a 12-month mobile phone intervention to improve vaccination among 0-11 months old children in rural hard-to-reach and urban street dweller areas. Softw...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2015.11.024

authors： Uddin MJ,Shamsuzzaman M,Horng L,Labrique A,Vasudevan L,Zeller K,Chowdhury M,Larson CP,Bishai D,Alam N

更新日期：2016-01-04 00:00:00
Evaluation of an intracellular-activated promoter for the generation of live Salmonella recombinant vaccines.
abstract：:Salmonella enterica serovar Typhimurium is a versatile host organism for the generation of recombinant live vaccines for mucosal immunization. We investigated the performance of an intracellular-activated promoter for expression of heterologous antigens by Salmonella carrier strains. We observed that intracellular exp...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2004.11.035

authors： Husseiny MI,Hensel M

更新日期：2005-04-08 00:00:00
Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
abstract：:Therapeutic immunization of HIV-1-infected individuals with or without anti-retroviral therapy is a new promising disease prevention. To induce a new cytotoxic T(CD8) lymphocyte (CTL) immunity during chronic HIV-1 infection 15 infrequently targeted but conserved HLA-supertype binding CTL epitopes from Gag, Pol, Nef, E...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2011.07.025

authors： Fomsgaard A,Karlsson I,Gram G,Schou C,Tang S,Bang P,Kromann I,Andersen P,Andreasen LV

更新日期：2011-09-16 00:00:00
No effect of an additional early dose of measles vaccine on hospitalization or mortality in children: A randomized controlled trial.
abstract：BACKGROUND:Non-specific effects (NSEs) of vaccines have increasingly gained attention in recent years. Recent studies suggest that live vaccines, such as measles vaccine (MV), have beneficial effects on health, while inactivated vaccines, such as the diphtheria-tetanus-pertussis (DTP) vaccine, may have harmful effects....

journal_title：Vaccine

pub_type： 临床试验,杂志文章,随机对照试验

doi：10.1016/j.vaccine.2018.02.104

authors： Schoeps A,Nebié E,Fisker AB,Sié A,Zakane A,Müller O,Aaby P,Becher H

更新日期：2018-04-05 00:00:00
Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
abstract：:The outer capsid protein VP4 is an important target for the development of a recombinant rotavirus vaccine because it mediates the attachment and penetration of rotavirus. Due to the poor solubility of full-length VP4, VP8 was explored as candidate rotavirus vaccines in the past years. In previous studies, it has been...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2018.03.011

authors： Li Y,Xue M,Yu L,Luo G,Yang H,Jia L,Zeng Y,Li T,Ge S,Xia N

更新日期：2018-04-12 00:00:00
Surveillance for adverse events after DTwP/Hib vaccination in Brazil: sensitivity and factors associated with reporting.
abstract：:We estimated the sensitivity, i.e., the proportion of all cases of adverse events following immunization (AEFIs) reported to the Brazilian passive surveillance for adverse events following immunization (PSAEFI) with the diphtheria-tetanus-whole-cell pertussis-Haemophilus influenzae type b (DTwP/Hib) vaccine, as well a...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2010.02.059

authors： Monteiro SA,Takano OA,Waldman EA

更新日期：2010-04-19 00:00:00
Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi.
abstract：:Successful vaccination of mice against an otherwise lethal challenge with the Peru strain of Trypanosoma cruzi necessitates the induction of a strong cell mediated immune response. Previously, immunization of mice with the paraflagellar rod proteins from Trypanosoma cruzi90% reduction in parasitemia in immunized mice ...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/s0264-410x(99)00380-1

authors： Wrightsman RA,Manning JE

更新日期：2000-01-31 00:00:00
A Rift Valley fever vaccine trial: 2. Serological response to booster doses with a comparison of intradermal versus subcutaneous injection.
abstract：:A booster dose of a formalin-inactivated, cell culture-propagated Rift Valley fever vaccine (TSI-GSD-200) was administered without significant reactogenicity to 60 volunteers 18 months after they received a three dose primary series. Blood was drawn for serological testing prior to boosting and 10, 49, and 180 days th...

journal_title：Vaccine

pub_type： 临床试验,杂志文章,随机对照试验

doi：10.1016/0264-410x(85)90060-x

authors： Kark JD,Aynor Y,Peters CJ

更新日期：1985-06-01 00:00:00
Seasonal influenza vaccine effectiveness against medically attended influenza illness among children aged 6-59 months, October 2011-September 2012: A matched test-negative case-control study in Suzhou, China.
abstract：BACKGROUND:Seasonal influenza infections among young children in China lead to substantial numbers of hospitalizations and financial burden. This study assessed the seasonal influenza vaccine effectiveness (VE) against laboratory confirmed medically attended influenza illness among children in Suzhou, China, from Octob...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2016.03.056

authors： Wang Y,Zhang T,Chen L,Greene C,Ding Y,Cheng Y,Yang C,Zeng S,Hua J,Zhou S,Song Y,Luan L,Zhang J,Zhao G

更新日期：2016-05-05 00:00:00
National survey of invasive pneumococcal diseases in Taiwan under partial PCV7 vaccination in 2007: emergence of serotype 19A with high invasive potential.
abstract：:We conducted an active, population-based laboratory surveillance study to evaluate the epidemiologic features of invasive pneumococcal disease (IPD) in Taiwan. Concurrently, nasopharyngeal colonization of Streptococcus pneumoniae was evaluated among 1128 healthy children aged
journal_title：Vaccine

pub_type： 杂志文章,多中心研究

doi：10.1016/j.vaccine.2009.06.091

authors： Hsieh YC,Lin PY,Chiu CH,Huang YC,Chang KY,Liao CH,Chiu NC,Chuang YC,Chen PY,Chang SC,Liu JW,Yen MY,Wang JH,Liu CY,Lin TY

更新日期：2009-09-04 00:00:00
Burden of rotavirus disease and cost-effectiveness of universal vaccination in the Province of Genoa (Northern Italy).
abstract：:Rotavirus is acknowledged to be a major cause of acute gastroenteritis in infants and young children. As gastroenteritis due to rotavirus is a public health problem and two new vaccines are currently available, we investigated the rotavirus burden and developed a cost-effectiveness analysis, using data collected in th...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2009.01.054

authors： Panatto D,Amicizia D,Ansaldi F,Marocco A,Marchetti F,Bamfi F,Giacchino R,Tacchella A,Del Buono S,Gasparini R

更新日期：2009-05-26 00:00:00
Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)?
abstract：:Viral hepatitis remains a major contributor to the global disease burden. Mass immunisation strategies against hepatitis B have been adopted by more than 90 developing and industrialised countries. Countries with low hepatitis A endemicity are experiencing cyclical outbreaks and an epidemiological shift, with larger n...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/s0264-410x(00)00193-6

authors： Lopalco PL,Salleras L,Barbuti S,Germinario C,Bruguera M,Buti M,Domínguez A

更新日期：2000-10-15 00:00:00
Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector.
abstract：:CD8(+) T-cell responses provide beneficial antiviral immunity against human immunodeficiency virus 1 (HIV-1). In this study, we show that intragastric vaccination with a Salmonella HIV-1 Env DNA vaccine vector generates Env-specific CD8(+) T-cells, both in mucosal and systemic lymphoid tissue. By contrast, intramuscul...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/s0264-410x(01)00330-9

authors： Shata MT,Reitz MS Jr,DeVico AL,Lewis GK,Hone DM

更新日期：2001-11-12 00:00:00
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.
abstract：BACKGROUND:Human immunodeficiency virus (HIV)-infected persons are at risk for severe influenza infections. Although vaccination against the H1N1 pandemic influenza strain is recommended, currently there are no data on the durability of post-vaccination antibody responses in this population. METHODS:HIV-infected and H...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2011.02.040

authors： Crum-Cianflone NF,Iverson E,Defang G,Blair PJ,Eberly LE,Maguire J,Ganesan A,Faix D,Duplessis C,Lalani T,Whitman T,Brandt C,Macalino G,Millar EV,Burgess T

更新日期：2011-04-12 00:00:00
The respiratory syncytial virus fusion protein formulated with a novel combination adjuvant induces balanced immune responses in lambs with maternal antibodies.
abstract：:Respiratory syncytial virus (RSV) causes severe respiratory illness in infants. There are no licensed vaccines to prevent RSV infection. The neonate receives short-term protection from maternally derived antibodies, which, however, can also interfere with the active response to vaccination. A RSV vaccine consisting of...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2015.01.041

authors： Garg R,Latimer L,Gerdts V,Potter A,van Drunen Littel-van den Hurk S

更新日期：2015-03-10 00:00:00
The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
abstract：:Recently the urgency of developing a pandemic influenza vaccine has lead to the re-evaluation of the use of whole virus vaccine. We have compared the humoral immune response and the protective efficacy of whole and split influenza virus vaccines in mice. Whole virus vaccine was more immunogenic particularly after the ...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/j.vaccine.2006.05.040

authors： Cox RJ,Hovden AO,Brokstad KA,Szyszko E,Madhun AS,Haaheim LR

更新日期：2006-11-10 00:00:00
The level of protection against rotavirus shedding in mice following immunization with a chimeric VP6 protein is dependent on the route and the coadministered adjuvant.
abstract：:Intranasal (i.n.) immunization of BALB/c mice with chimeric murine rotavirus EDIM (epizootic diarrhea of infant mice) VP6 and attenuated E. coli heat-labile toxin (LT), LT(R192G), stimulated >99% protection against rotavirus shedding after EDIM challenge. Here, we evaluated other potential adjuvants with chimeric VP6 ...

journal_title：Vaccine

pub_type： 杂志文章

doi：10.1016/s0264-410x(02)00043-9

authors： Choi AH,McNeal MM,Flint JA,Basu M,Lycke NY,Clements JD,Bean JA,Davis HL,McCluskie MJ,VanCott JL,Ward RL

更新日期：2002-03-15 00:00:00